{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,6,25]],"date-time":"2025-06-25T04:09:58Z","timestamp":1750824598464,"version":"3.41.0"},"reference-count":25,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2025,6,24]]},"DOI":"10.7759\/cureus.86669","type":"journal-article","created":{"date-parts":[[2025,6,24]],"date-time":"2025-06-24T16:43:29Z","timestamp":1750783409000},"source":"Crossref","is-referenced-by-count":0,"title":["Silent Yet Striking: Medullary Carcinoma Behind an Intestinal Obstruction"],"prefix":"10.7759","author":[{"given":"Nasim","family":"Salimiaghdam","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ahmed","family":"Mustafa","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Irene  O","family":"Pokuaa","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Afshin","family":"Hamidi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Emily","family":"Chen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.3322\/caac.21660","article-title":"Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries","volume":"71","author":"Sung H","year":"2021","unstructured":"Sung H, Ferlay J, Siegel RL, Laversanne M, Soerjomataram I, Jemal A, Bray F. Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin. 2021, 71:209-49. 10.3322\/caac.21660","journal-title":"CA Cancer J Clin"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.1016\/j.humpath.2016.02.018","article-title":"Medullary carcinoma in the colorectum: a systematic review and meta-analysis","volume":"53","author":"Pyo JS","year":"2016","unstructured":"Pyo JS, Sohn JH, Kang G. Medullary carcinoma in the colorectum: a systematic review and meta-analysis. Hum Pathol. 2016, 53:91-6. 10.1016\/j.humpath.2016.02.018","journal-title":"Hum Pathol"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.1016\/S0002-9440(10)63994-6","article-title":"Histopathological identification of colon cancer with microsatellite instability","volume":"158","author":"Alexander J","year":"2001","unstructured":"Alexander J, Watanabe T, Wu TT, Rashid A, Li S, Hamilton SR. Histopathological identification of colon cancer with microsatellite instability. Am J Pathol. 2001, 158:527-35. 10.1016\/S0002-9440(10)63994-6","journal-title":"Am J Pathol"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.1999.17.8.2429","article-title":"Medullary-type poorly differentiated adenocarcinoma of the large bowel: a distinct clinicopathologic entity characterized by microsatellite instability and improved survival","volume":"17","author":"Lanza G","year":"1999","unstructured":"Lanza G, Gaf\u00e0 R, Matteuzzi M, Santini A. Medullary-type poorly differentiated adenocarcinoma of the large bowel: a distinct clinicopathologic entity characterized by microsatellite instability and improved survival. J Clin Oncol. 1999, 17:2429-38. 10.1200\/JCO.1999.17.8.2429","journal-title":"J Clin Oncol"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.1053\/j.gastro.2009.12.064","article-title":"Microsatellite instability in colorectal cancer","volume":"138","author":"Boland CR","year":"2010","unstructured":"Boland CR, Goel A. Microsatellite instability in colorectal cancer. Gastroenterology. 2010, 138:2073-2087.e3. 10.1053\/j.gastro.2009.12.064","journal-title":"Gastroenterology"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.1126\/science.aan6733","article-title":"Mismatch repair deficiency predicts response of solid tumors to PD-1 blockade","volume":"357","author":"Le DT","year":"2017","unstructured":"Le DT, Durham JN, Smith KN, et al.. Mismatch repair deficiency predicts response of solid tumors to PD-1 blockade. Science. 2017, 357:409-13. 10.1126\/science.aan6733","journal-title":"Science"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa022289","article-title":"Tumor microsatellite-instability status as a predictor of benefit from fluorouracil-based adjuvant chemotherapy for colon cancer","volume":"349","author":"Ribic CM","year":"2003","unstructured":"Ribic CM, Sargent DJ, Moore MJ, et al.. Tumor microsatellite-instability status as a predictor of benefit from fluorouracil-based adjuvant chemotherapy for colon cancer. N Engl J Med. 2003, 349:247-57. 10.1056\/NEJMoa022289","journal-title":"N Engl J Med"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.1053\/j.gastro.2014.12.035","article-title":"Nutrients, foods, and colorectal cancer prevention","volume":"148","author":"Song M","year":"2015","unstructured":"Song M, Garrett WS, Chan AT. Nutrients, foods, and colorectal cancer prevention. Gastroenterology. 2015, 148:1244-60.e16. 10.1053\/j.gastro.2014.12.035","journal-title":"Gastroenterology"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa2017699","article-title":"Pembrolizumab in microsatellite-instability-high advanced colorectal cancer","volume":"383","author":"Andr\u00e9 T","year":"2020","unstructured":"Andr\u00e9 T, Shiu KK, Kim TW, et al.. Pembrolizumab in microsatellite-instability-high advanced colorectal cancer. N Engl J Med. 2020, 383:2207-18. 10.1056\/NEJMoa2017699","journal-title":"N Engl J Med"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.1016\/s0046-8177(99)90146-6","article-title":"Medullary adenocarcinoma of the colon: clinicopathologic study of 11 cases","volume":"30","author":"Jessurun J","year":"1999","unstructured":"Jessurun J, Romero-Guadarrama M, Manivel JC. Medullary adenocarcinoma of the colon: clinicopathologic study of 11 cases. Hum Pathol. 1999, 30:843-8. 10.1016\/s0046-8177(99)90146-6","journal-title":"Hum Pathol"},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.3390\/ijms21249680","article-title":"Prognostic and Predictive Cross-Roads of Microsatellite Instability and Immune Response to Colon Cancer","volume":"21","author":"Laghi L","year":"2020","unstructured":"Laghi L, Negri F, Gaiani F, Cavalleri T, Grizzi F, De' Angelis GL, Malesci A. Prognostic and Predictive Cross-Roads of Microsatellite Instability and Immune Response to Colon Cancer. Int J Mol Sci. 2020, 21:9680. 10.3390\/ijms21249680","journal-title":"Int J Mol Sci"},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.6004\/jnccn.2018.0021","article-title":"NCCN Guidelines Insights: Colon Cancer, Version 2.2018","volume":"16","author":"Benson AB","year":"2018","unstructured":"Benson AB, Venook AP, Al-Hawary MM, et al.. NCCN Guidelines Insights: Colon Cancer, Version 2.2018. J Natl Compr Canc Netw. 2018, 16:359-69. 10.6004\/jnccn.2018.0021","journal-title":"J Natl Compr Canc Netw"},{"key":"ref13","doi-asserted-by":"publisher","DOI":"10.1136\/gut.42.6.673","article-title":"Morphology of sporadic colorectal cancer with DNA replication errors","volume":"42","author":"Jass JR","year":"1998","unstructured":"Jass JR, Do KA, Simms LA, et al.. Morphology of sporadic colorectal cancer with DNA replication errors. Gut. 1998, 42:673-9. 10.1136\/gut.42.6.673","journal-title":"Gut"},{"key":"ref14","doi-asserted-by":"publisher","DOI":"10.1016\/S1470-2045(17)30422-9","article-title":"Nivolumab in patients with metastatic DNA mismatch repair-deficient or microsatellite instability-high colorectal cancer (CheckMate 142): an open-label, multicentre, phase 2 study","volume":"18","author":"Overman MJ","year":"2017","unstructured":"Overman MJ, McDermott R, Leach JL, et al.. Nivolumab in patients with metastatic DNA mismatch repair-deficient or microsatellite instability-high colorectal cancer (CheckMate 142): an open-label, multicentre, phase 2 study. Lancet Oncol. 2017, 18:1182-91. 10.1016\/S1470-2045(17)30422-9","journal-title":"Lancet Oncol"},{"key":"ref15","doi-asserted-by":"publisher","DOI":"10.4251\/wjgo.v5.i2.12","article-title":"Era of universal testing of microsatellite instability in colorectal cancer","volume":"5","author":"Zhang X","year":"2013","unstructured":"Zhang X, Li J. Era of universal testing of microsatellite instability in colorectal cancer. World J Gastrointest Oncol. 2013, 5:12-9. 10.4251\/wjgo.v5.i2.12","journal-title":"World J Gastrointest Oncol"},{"key":"ref16","article-title":"Prognostic impact of microsatellite instability in colorectal cancer patients treated with adjuvant FOLFOX","volume":"30","author":"Des Guetz G","year":"2010","unstructured":"Des Guetz G, Lecaille C, Mariani P, et al.. Prognostic impact of microsatellite instability in colorectal cancer patients treated with adjuvant FOLFOX. Anticancer Res. 2010, 30:4297-301.","journal-title":"Anticancer Res"},{"key":"ref17","doi-asserted-by":"publisher","DOI":"10.1245\/s10434-014-4355-5","article-title":"Medullary colorectal carcinoma revisited: a clinical and pathological study of 102 cases","volume":"22","author":"Knox RD","year":"2015","unstructured":"Knox RD, Luey N, Sioson L, et al.. Medullary colorectal carcinoma revisited: a clinical and pathological study of 102 cases. Ann Surg Oncol. 2015, 22:2988-96. 10.1245\/s10434-014-4355-5","journal-title":"Ann Surg Oncol"},{"key":"ref18","doi-asserted-by":"publisher","DOI":"10.6004\/jnccn.2021.0012","article-title":"Colon cancer, version 2.2021, NCCN Clinical Practice Guidelines in Oncology","volume":"19","author":"Benson AB","year":"2021","unstructured":"Benson AB, Venook AP, Al-Hawary MM, et al.. Colon cancer, version 2.2021, NCCN Clinical Practice Guidelines in Oncology. J Natl Compr Canc Netw. 2021, 19:329-59. 10.6004\/jnccn.2021.0012","journal-title":"J Natl Compr Canc Netw"},{"key":"ref19","article-title":"Immunotherapy in microsatellite instability metastatic colorectal cancer: Current status and future perspectives","volume":"7","author":"Motta R","year":"2021","unstructured":"Motta R, Cabezas-Camarero S, Torres-Mattos C, Riquelme A, Calle A, Figueroa A, Sotelo MJ. Immunotherapy in microsatellite instability metastatic colorectal cancer: Current status and future perspectives. J Clin Transl Res. 2021, 7:511-22.","journal-title":"J Clin Transl Res"},{"key":"ref20","doi-asserted-by":"crossref","DOI":"10.21873\/anticanres.13857","article-title":"Microsatellite instability and survival in stage II colorectal cancer: a systematic review and meta-analysis","volume":"39","author":"Petrelli F","year":"2019","unstructured":"Petrelli F, Ghidini M, Cabiddu M, et al.. Microsatellite instability and survival in stage II colorectal cancer: a systematic review and meta-analysis. Anticancer Res. 2019, 39:6431-41.","journal-title":"Anticancer Res"},{"key":"ref21","doi-asserted-by":"publisher","DOI":"10.1097\/DCR.0000000000001332","article-title":"Prognostic impact of tumor-infiltrating lymphocytes in primary and metastatic colorectal cancer: a systematic review and meta-analysis","volume":"62","author":"Kong JC","year":"2019","unstructured":"Kong JC, Guerra GR, Pham T, et al.. Prognostic impact of tumor-infiltrating lymphocytes in primary and metastatic colorectal cancer: a systematic review and meta-analysis. Dis Colon Rectum. 2019, 62:498-508. 10.1097\/DCR.0000000000001332","journal-title":"Dis Colon Rectum"},{"key":"ref22","doi-asserted-by":"publisher","DOI":"10.1053\/j.seminoncol.2011.05.005","article-title":"Challenges in the management of stage II colon cancer","volume":"38","author":"Dotan E","year":"2011","unstructured":"Dotan E, Cohen SJ. Challenges in the management of stage II colon cancer. Semin Oncol. 2011, 38:511-20. 10.1053\/j.seminoncol.2011.05.005","journal-title":"Semin Oncol"},{"key":"ref23","doi-asserted-by":"publisher","DOI":"10.3389\/fonc.2022.888181","article-title":"Microsatellite instability and metastatic colorectal cancer - a clinical perspective","volume":"12","author":"Buchler T","year":"2022","unstructured":"Buchler T. Microsatellite instability and metastatic colorectal cancer - a clinical perspective. Front Oncol. 2022, 12:888181. 10.3389\/fonc.2022.888181","journal-title":"Front Oncol"},{"key":"ref24","doi-asserted-by":"publisher","DOI":"10.1016\/j.ctrv.2016.10.005","article-title":"The evolving role of microsatellite instability in colorectal cancer: a review","volume":"51","author":"Gelsomino F","year":"2016","unstructured":"Gelsomino F, Barbolini M, Spallanzani A, Pugliese G, Cascinu S. The evolving role of microsatellite instability in colorectal cancer: a review. Cancer Treat Rev. 2016, 51:19-26. 10.1016\/j.ctrv.2016.10.005","journal-title":"Cancer Treat Rev"},{"key":"ref25","doi-asserted-by":"publisher","DOI":"10.1038\/modpathol.2016.54","article-title":"Medullary carcinoma of the colon: a distinct morphology reveals a distinctive immunoregulatory microenvironment","volume":"29","author":"Friedman K","year":"2016","unstructured":"Friedman K, Brodsky AS, Lu S, et al.. Medullary carcinoma of the colon: a distinct morphology reveals a distinctive immunoregulatory microenvironment. Mod Pathol. 2016, 29:528-41. 10.1038\/modpathol.2016.54","journal-title":"Mod Pathol"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/378783-silent-yet-striking-medullary-carcinoma-behind-an-intestinal-obstruction","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,6,24]],"date-time":"2025-06-24T16:43:29Z","timestamp":1750783409000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/378783-silent-yet-striking-medullary-carcinoma-behind-an-intestinal-obstruction"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,6,24]]},"references-count":25,"URL":"https:\/\/doi.org\/10.7759\/cureus.86669","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2025,6,24]]}}}